Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression

Depression and Anxiety

Volumn 28, Issue 4, 2011, Pages 297-302

  Abolfazli, Roya ^a   Hosseini, Mahdi ^b   Ghanizadeh, Ahmad ^b   Ghaleiha, Ali ^c   Tabrizi, Mina ^d   Raznahan, Maedeh ^e   Golalizadeh, Mousa ^f   Akhondzadeh, Shahin ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Clinical trial; Fluoxetine; Major depression; Modafinil

Indexed keywords

FLUOXETINE; MODAFINIL; PLACEBO;

ADULT; ANXIETY; APPETITE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; NAUSEA; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SIDE EFFECT; SWEATING; TREATMENT OUTCOME; TREMOR;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; IRAN; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHOMETRICS; YOUNG ADULT;

EID: 79953741376     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20801     Document Type: Article

References (26)

1. Sen S, Sanacora G. Major depression: emerging therapeutics. Mt Sinai J Med 2008;75:204-225.
2. Belmaker RH. The future of depression psychopharmacology. CNS Spectr 2008;13:682-687.
3. Trivedi MH. Treating depression to full remission. J Clin Psychiatry 2009;70:e01
4. Mendlewicz J. Towards achieving remission in the treatment of depression. Dialogues Clin Neurosci 2008;10:371-375.
5. Richelson E. Pharmacology of antidepressants-characteristic of the ideal drug. Mayo Clin Proc 1994;69:1069-1081.
6. Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 2009;70:16-25.
7. Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs 2008;68:1803-1839.
8. Fava M, Thase ME, DeBattista C, et al. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry 2007;19:153-159. (Pubitemid 47345870)
9. Amiri S, Mohammadi MR, Mohammadi M, et al. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:145-149.
10. Kahbazi M, Ghoreishi A, Rahiminejad F, et al. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res 2009;168:234-237.
11. Menza MA, Kaufmann KR, Castellanous AM. Modafinil augmentation of antidepresant treatment in depression. J Clin Psychiatry 2000;61:378-381. (Pubitemid 30345941)
12. Rasmussen NA, Schroder P, Olsen LR, et al. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Nord J Psychiatry 2005;59:173-178. (Pubitemid 40946275)
13. DeBattista C, Doghramji K, Menza MA. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003;64: 1057-1064. (Pubitemid 37158251)
14. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005;66:85-93.
15. Dunlop BW, Crits-Christoph P, Evans DL, et al. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. J Clin Psychopharmacol 2007;27:614-619. (Pubitemid 351339449)
16. Ballon JS, Feifel D. A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry 2006; 67:554-566. (Pubitemid 43764232)
17. Hamilton M. A rating scale for depression. J Neuro Neurosurg Psychiatry 1960;3:62-66.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
19. Akhondzadeh S, Jafari S, Raisi F, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 2009;26:607-611.
20. Moshiri E, Basti AA, Noorbala AA, et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 2006; 13:607-611.
21. Akhondzadeh Basti A, Moshiri E, Noorbala AA, et al. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:439-442. (Pubitemid 46209441)
22. Chang T, Fava M. The future of psychopharmacology of depression. J Clin Psychiatry 2010;71:971-975.
23. Ferraro L, Fuxe K, Tanganelli S, et al. Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression. J Neurosci Res 2002;68:107-112. (Pubitemid 34275003)
24. DeBattista C, Lembke A, Solvason HB, et al. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol 2004;24:87-90. (Pubitemid 38134171)
25. Price CS, Taylor FB. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy. Depress Anxiety 2005;21:149-153 (Pubitemid 41170383)
26. Robertson P, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 2003;42:123-137. (Pubitemid 36188553)